Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
23 employees
MedTrans Go: B2B healthcare system providing non-emergency medical transport and reducing appointment cancellations.
HQ
Founded
2017
Founded with the mission to optimize healthcare appointments and reduce cancellations, MedTrans Go is a B2B service provider focusing on non-emergency medical transportation. The company offers a comprehensive suite of services including transportation, interpretation, home health care, and delivery. Their platform aims to streamline care coordination, allowing healthcare providers to schedule, dispatch, track, and invoice services efficiently. MedTrans Go's vision is to eliminate the logistical challenges in healthcare, thereby improving efficiency and maximizing revenue for medical practices.
Notable figures affiliated with MedTrans Go include key investors and industry experts who have recognized the significant impact of reducing appointment cancellations on the healthcare system. The company has achieved substantial milestones, such as significantly lowering patient no-show rates and enhancing operational efficiency for their clients. MedTrans Go's innovative approach has made a meaningful impact on the healthcare industry by addressing a $150 billion problem, ultimately contributing to better patient outcomes and more sustainable healthcare practices.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Home Health Care, Medical Transportation
Technology
Logistics, Healthcare
Tags
Healthtech, SaaS
Model Types
Platform, Software
Revenue Type(s)
Transactional, Recurring
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was MedTrans Go founded?
MedTrans Go was founded in 2017.
Where is MedTrans Go's headquarters located?
MedTrans Go's headquarters is located in Atlanta, GA, US.
When was MedTrans Go's last funding round?
MedTrans Go's most recent funding round was for $2.9M (USD) in January 2023.
How many employees does MedTrans Go have?
MedTrans Go has 23 employees as of Feb 5, 2024.
How much has MedTrans Go raised to-date?
As of July 05, 2023, MedTrans Go has raised a total of $4.5M (USD) since Jan 25, 2023.
Add Comparison
Total Raised to Date
$4.5M
USD
Last Update Jan 25, 2023
Last Deal Details
$2.9M
USD
Jan 25, 2023
Series Unknown
Current Employees
23
Last updated: Feb 5, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts